List of insiders holdings for Quince Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| Lamond David Director | 2023-12-14 18:21:33 | 2,604,120 4,082,267 | 6,686,387 | Form 4 |
| LAMOND PIERRE Lamond Christine 10% Owner | 2019-09-30 08:43:53 | 2,886,530 0 | 2,886,530 | Form 13G |
| Thye Dirk CEO AND CHIEF MEDICAL OFFICER | 2024-02-02 17:50:21 | 1,500,000 0 | 1,500,000 | Form 4 |
| PFIZER INC Pfizer Strategic Investment Holdings LLC Pfizer Ventures (US) LLC 10% Owner | 2022-02-11 18:06:57 | 600,000 0 | 600,000 | Form 13G |
| Hannah Brendan CHIEF BUSINESS OFFICER AND COO | 2024-02-02 17:53:07 | 600,000 0 | 600,000 | Form 4 |
| Low Philip S Director | 2022-05-23 20:17:43 | 477,367 63,974 | 541,341 | Form 4 |
| Lynch Casey Chief Executive Officer | 2022-01-05 17:26:18 | 440,000 0 | 440,000 | Form 4 |
| Janhofer Guenter Chief Scientific Officer | 2023-10-24 19:42:07 | 300,000 0 | 300,000 | Form 4 |
| LOWE CHRISTOPHER P. Interim CEO, COO & CFO | 2022-03-04 17:55:40 | 265,000 0 | 265,000 | Form 4 |
| Smith Karen L. Chief Medical Officer | 2023-02-02 18:35:56 | 225,000 0 | 225,000 | Form 4 |
| Holsinger Leslie EVP, Preclinical Development | 2022-06-08 16:10:58 | 148,080 0 | 148,080 | Form 4 |
| Ryan Charles S. PRESIDENT | 2024-02-02 18:02:04 | 145,000 0 | 145,000 | Form 4 |
| Detke Michael J. Chief Medical Officer | 2022-03-04 17:39:59 | 140,000 0 | 140,000 | Form 4 |
| Dominy Stephen S. Chief Scientific Officer | 2022-01-05 16:53:10 | 125,000 0 | 125,000 | Form 4 |
| McDowell Caryn Gordon Chief Legal & Adm. Officer | 2022-06-08 16:09:19 | 122,500 0 | 122,500 | Form 4 |
| Gafric Kristen SVP, Legal & Administration | 2020-02-10 18:13:59 | 100,000 0 | 100,000 | Form 4 |
| Takeda Ventures Inc. TAKEDA PHARMACEUTICAL CO LTD Takeda Pharmaceuticals International AG Takeda Pharmaceuticals U.S.A. Inc. 10% Owner | 2021-01-28 17:57:44 | 87,258 0 | 87,258 | Form 13G |
| Benatti Luca Director | 2023-10-24 19:46:54 | 54,000 0 | 54,000 | Form 4 |
| Patni Rajiv Director | 2024-02-15 18:14:09 | 54,000 0 | 54,000 | Form 4 |
| Monohon Ted Chief Accounting Officer & VP | 2023-03-06 18:55:56 | 27,440 0 | 27,440 | Form 4 |
| RYAN UNA S Director | 2023-05-26 17:50:54 | 27,000 0 | 27,000 | Form 4 |
| Senner Christopher J. Director | 2023-05-26 17:53:52 | 27,000 0 | 27,000 | Form 4 |
| Bray June Director | 2023-05-26 17:45:03 | 27,000 0 | 27,000 | Form 4 |
| Sabbagh Marwan Director | 2022-03-16 18:33:46 | 22,058 0 | 22,058 | Form 4 |
| YOUNG KEVIN Director | 2020-06-09 20:22:01 | 11,029 0 | 11,029 | Form 4 |
| McLoughlin Margaret Director | 2023-08-09 18:18:36 | 8000 0 | 8000 | Form 4 |
| EPIQ Capital Group LLC Boeding Chad Former 10% Owner | 2021-02-01 16:25:27 | 0 0 | 0 | Form 5 |